Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

Presentation TCT 2022

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Presenter: Santiago Garcia

September 18, 2022

News Conference News TCT 2022

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Yael L. Maxwell

September 18, 2022

Presentation TCT 2022

Transfemoral Sapien in MAC

Presenter: Matthew A. Romano

September 17, 2022

Presentation TCT 2022

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Presenter: Jonas Lanz

September 17, 2022

Presentation TCT 2022

TCT 749: Edwards SAPIEN 3 delivery system failure and management

Presenter: Miha Sustersic

September 17, 2022

Video

» Interview

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

September 18, 2022

Video

» Interview

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

September 18, 2022

Advertisement

Valve Fracture for ViV TAVI Linked With Higher Mortality

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Transfemoral Sapien in MAC

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

TCT 749: Edwards SAPIEN 3 delivery system failure and management

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content